Rationale Nachsorge des nicht-muskelinvasiven HarnblasenkarzinomsRational follow-up of non-muscle invasive bladder cancer

[1] Sylvester RJ(2006)Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 466-475

[2] van der Meijden AP(2021)European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update Eur Urol 79 62-79

[3] Oosterlinck W(2011)The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin: external validation of the EORTC risk tables Eur Urol 60 423-430

[4] Witjes JA(2014)Comparison of expected treatment outcomes, obtained using risk models and international guidelines, with observed treatment outcomes in a Dutch cohort of patients with non-muscle-invasive bladder cancer treated with intravesical chemotherapy BJU Int 114 193-201

[5] Bouffioux C(2013)Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data Eur Urol 64 846-854

[6] Denis L(2016)Replacing cystosopy by urine markers in the follow-up of patients with low risk non muscle-invasive bladder cancer? Urol Oncol 34 452-459

[7] Newling DW(2002)Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression J Urol 167 1634-1637

[8] Kurth K(2008)Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year Urol Int 80 124-128

[9] Rouprêt M(2013)Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer J Urol 190 1187-1191

[10] Babjuk M(2010)Performance of computed tomographic urography in diagnosis of upper urinary tract urothelial carcinoma, in patients presenting with hematuria: systematic review and meta-analysis Eur J Radiol 73 334-338

[1] Sylvester RJ(2006)Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 466-475

[2] van der Meijden AP(2021)European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update Eur Urol 79 62-79

[3] Oosterlinck W(2011)The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin: external validation of the EORTC risk tables Eur Urol 60 423-430

[4] Witjes JA(2014)Comparison of expected treatment outcomes, obtained using risk models and international guidelines, with observed treatment outcomes in a Dutch cohort of patients with non-muscle-invasive bladder cancer treated with intravesical chemotherapy BJU Int 114 193-201

[5] Bouffioux C(2013)Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data Eur Urol 64 846-854

[6] Denis L(2016)Replacing cystosopy by urine markers in the follow-up of patients with low risk non muscle-invasive bladder cancer? Urol Oncol 34 452-459

[7] Newling DW(2002)Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression J Urol 167 1634-1637

[8] Kurth K(2008)Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year Urol Int 80 124-128

[9] Rouprêt M(2013)Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer J Urol 190 1187-1191

[10] Babjuk M(2010)Performance of computed tomographic urography in diagnosis of upper urinary tract urothelial carcinoma, in patients presenting with hematuria: systematic review and meta-analysis Eur J Radiol 73 334-338